| ZEVRA THERAPEUTICS |
| USA |
| Gesundheit |
| US4884452065 / A2QLX7 |
| 1GDA (Frankfurt) / ZVRA (NASDAQ) |
| FRA:1GDA, ETR:1GDA, 1GDA:GR, NASDAQ:ZVRA |
| - |
| https://zevra.com/ |
|
Zevra Therapeutics Inc. is a pharmaceutical compan..
>Volltext.. |
| 420.91 Mio. EUR |
| 303.16 Mio. EUR |
| 71.21 Mio. EUR |
| -19.94 Mio. EUR |
| 29.81 Mio. EUR |
| 0.53 EUR |
| 52.92 Mio. EUR |
| 45.94 Mio. EUR |
| -19.72 Mio. EUR |
| 7.64 |
| 223.05% |
| - |
| - |
| - |
| - |
| ZEVRA |
| 03.02.26 |
|
||||
|
||||
|